Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2010
06/15/2010US7736847 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
06/15/2010US7736846 Contacting a cell comprising a compound, determining the effect of the compound upon the cell comprising the polypeptide or fragment thereof, thereby identifying a compound that modulates
06/15/2010US7736654 Proteins, polynucleotides, antibodies, transgenic animals, hybridoma; humoral or cellular immune response; pancreatic
06/15/2010US7736645 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis
06/15/2010US7736643 A mutant hydrolase protein of Candida comprising an amino acid sequence, where the #219 leucine is replaced by a hydrophilic amino acid selected from glutamine, histidine, arginine, lysine, serine, threonine, aspartic acid and glutamic acid, used in the food and detergent industry
06/15/2010US7736640 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression
06/15/2010US7736623 providing semi-automated measurements of the ventricular system by MRI scans using quantitative anatomical protocols, determining a measurement of biomarker levels in CSF that has been extracted, correcting measurement of the level biomarker according to the ventricular size, providing a corrected result
06/15/2010US7736588 Apparatus for use in the detection of residual antibiotics in food, milk and bolily fluids
06/15/2010CA2576142C Dna decontamination method
06/15/2010CA2410253C Regulating lipid levels via the zmax1 or hbm gene
06/15/2010CA2405050C Production of tcr gamma delta t cells
06/15/2010CA2404388C New prostate cell lines
06/15/2010CA2386115C Dna sequencing method
06/15/2010CA2350808C Chemiluminescent substrates for neuraminidase, assays for detection of neuraminidase and kits therefor
06/15/2010CA2294472C Torsin, torsin genes, and methods of use
06/15/2010CA2284119C Phosphatidyl-3,4,5-triphosphate-dependent protein kinase
06/15/2010CA2269109C Protease for activating clotting factor vii
06/15/2010CA2250000C Methods of modulating melanin synthesis
06/10/2010WO2010065953A1 T cell receptor alpha genes which predispose the airway to bacterial colonization
06/10/2010WO2010065940A1 Materials and methods for determining diagnosis and prognosis of prostate cancer
06/10/2010WO2010065927A2 Dna-damage-induced proteolysis
06/10/2010WO2010065926A2 Methods for screening, predicting and monitoring prostate cancer
06/10/2010WO2010065924A1 Compositions for improving gene amplification
06/10/2010WO2010065923A2 Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders
06/10/2010WO2010065916A1 Dna methylation based test for monitoring efficacy of treatment
06/10/2010WO2010065863A2 Assays for identifying genes encoding salty taste receptors and modulators
06/10/2010WO2010065850A2 Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition
06/10/2010WO2010065792A2 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
06/10/2010WO2010065787A2 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
06/10/2010WO2010065781A2 Lateral flow strip assay with immobilized conjugate
06/10/2010WO2010065776A2 Identification of neuroprotective agents using pro-inflammatory human glial cells
06/10/2010WO2010065742A1 Methods of measuring adamts13-mediated in vivo cleavage of von willebrand factor and uses thereof
06/10/2010WO2010065698A1 Device and methods for detection of microorganisms
06/10/2010WO2010065671A2 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
06/10/2010WO2010065662A2 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
06/10/2010WO2010065629A2 Nucleic acid amplification
06/10/2010WO2010065626A1 Genotyping tools, methods and kits
06/10/2010WO2010065576A2 The antisense transcriptomes of cells
06/10/2010WO2010065568A2 METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
06/10/2010WO2010065557A2 Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis
06/10/2010WO2010065541A2 Biomarkers useful in liver fibrosis diagnosis
06/10/2010WO2010065520A1 Methods for preparing aerolysin polypeptides or conjugates thereof
06/10/2010WO2010065477A2 Spinning force apparatus
06/10/2010WO2010065470A2 Compositions and methods for detecting background male dna during fetal sex determination
06/10/2010WO2010065420A2 Universal biological sample processing
06/10/2010WO2010065380A1 Methods for estimating target nucleic acid in a sample prior to amplification
06/10/2010WO2010065372A1 Liver cell toxicity assay
06/10/2010WO2010065343A2 Method of predicting the location of microbiologically influenced corrosion of underground items
06/10/2010WO2010065266A1 Chromatin structure detection
06/10/2010WO2010065245A1 Test kit and method for detecting bacteriophage
06/10/2010WO2010065156A1 Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer
06/10/2010WO2010064950A1 Biopreparation for neutralising bacillus anthracis spores and vegetative cells
06/10/2010WO2010064747A1 Kit for diagnosing and screening liver cancer comprising antibodies specific to protein markers derived from hbx transgenic mouse and method for diagnosing and screening liver cancer using it
06/10/2010WO2010064736A1 Therapeutic agent for cancer
06/10/2010WO2010064702A1 Biomarker for predicting prognosis of cancer
06/10/2010WO2010064700A1 Device for examining myocardial toxicity, chip for examining myocardial toxicity and method for examining myocardial toxicity
06/10/2010WO2010064634A1 Method for preparing fecal sample, solution for preparing fecal sample, and feces collection kit
06/10/2010WO2010064628A1 Method for preparing sample containing nucleic acid, solution for preparing sample, and method for analyzing nucleic acid
06/10/2010WO2010064223A2 Cytokines as prognostic markers of respiratory-tract infection following major surgery
06/10/2010WO2010064141A1 Assay
06/10/2010WO2010064040A1 Method for use in polynucleotide sequencing
06/10/2010WO2010064021A1 Method for identifying inhibitors of lipoteichoic acid synthase
06/10/2010WO2010064016A2 Methods for determining a prognosis in multiple myeloma
06/10/2010WO2010063886A1 Method for detection of autoimmune diseases
06/10/2010WO2010063839A2 Targets for treatment of chlamydial infections
06/10/2010WO2010063818A2 Methods for selecting protease resistant polypeptides
06/10/2010WO2010063754A1 Procedure for the diagnosis or prognosis of lung cancer and a kit for performing said procedure
06/10/2010WO2010063732A1 Novel combination of fluorescent dyes for the detection of nucleic acids
06/10/2010WO2010063683A1 Real time pcr through gigahertz or terahertz spectrometry
06/10/2010WO2010063640A1 Screening assays for the identification of bace2 inhibitors
06/10/2010WO2010063454A1 Method of stratifying breast cancer patients based on gene expression
06/10/2010WO2010063411A1 System and method for detection of hiv integrase variants
06/10/2010WO2010063121A1 Methods for biomarker identification and biomarker for non-small cell lung cancer
06/10/2010WO2010045211A3 Genetic loci associated with northern leaf blight resistance in maize
06/10/2010WO2010043973A3 Biomarkers for dengue
06/10/2010WO2010038083A3 Transcription factor decoys
06/10/2010WO2010034690A3 Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay
06/10/2010WO2010033677A3 Plasmonic electricity
06/10/2010WO2010031767A3 Fluorescent-labelled atpases
06/10/2010WO2010030604A3 Methods and compositions for determining and monitoring dietary supplementation
06/10/2010WO2010029378A3 Anti-protozoa compounds
06/10/2010WO2010028373A3 Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
06/10/2010WO2010028372A3 Methods and kits for the diagnosis of ryr1-related diseases
06/10/2010WO2010028098A3 Pathways underlying pancreatic tumorigenesis and an hereditary pancreatic cancer gene
06/10/2010WO2010018465A3 Methods for digital pcr
06/10/2010WO2010011281A3 Methods and compositions for the diagnosis and treatment of cancer
06/10/2010WO2010001358A3 Diagnostic polymorphisms for cardiac disease
06/10/2010WO2010000592A3 Cyclopeptides used as mmp-type protease enzyme inhibitors
06/10/2010WO2009154790A3 Novel metastasis suppressor genes and uses thereof
06/10/2010WO2009151584A3 Identification of contaminating bacteria in industrial ethanol fermentations
06/10/2010WO2009111661A9 Molecular diagnosis and classification of malignant melanoma
06/10/2010WO2009060217A8 Streptococcus pyogenes classification
06/10/2010WO2004044123A9 Bioinformatically detectable group of novel regulatory genes and uses thereof
06/10/2010US20100146663 Nucleotide Sequences and Polypeptides Encoded Thereby Useful for Modifying plant Characteristics
06/10/2010US20100146659 Plant Virus Designated Tomato Marchitez Virus
06/10/2010US20100146656 Parthenocarpic Genetic Elements Derived From S. Habrochaites
06/10/2010US20100146652 Xenobiotic related induction of gene expression
06/10/2010US20100145733 Blood Glucose Tracking Apparatus and Methods
06/10/2010US20100145626 Systems for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
06/10/2010US20100145625 Determination and prediction of the expression of traits of plants from the metabolite profile as a biomarker
1 ... 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 ... 3003